Tetsuo Maruyama
Tokyo, 1608582, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications
Rat-Specific Expression of Placental MATE1 Contributes to Species Difference in Fetal Transfer of Metformin and 1-Methyl-4-Phenylpyridinium.
Journal: Molecular pharmaceutics
Published: November 03, 2025
Impact of low-dose aspirin therapy initiation timing on pregnancy outcomes after frozen-thawed blastocyst transfer.
Journal: Journal of reproductive immunology
Published: November 04, 2024
Novel screening approach for stem cell selective inhibitors and their possible translational therapeutic potential for endometriosis.
Journal: Reproductive biology
Published: January 28, 2024
Therapeutic efficacy of the optimization of thyroid function, thrombophilia, immunity and uterine milieu (OPTIMUM) treatment strategy on pregnancy outcomes after single euploid blastocyst transfer in advanced age women with recurrent reproductive failure.
Journal: Reproductive medicine and biology
Published: October 10, 2023
A Decellularized Uterine Endometrial Scaffold Enhances Regeneration of the Endometrium in Rats.
Journal: International journal of molecular sciences
Published: January 08, 2023
Guidelines for Reproductive Medicine in Japan.
Journal: Reproductive medicine and biology
Published: July 31, 2022
A mediator complex subunit 12 gain-of-function mutation induces partial leiomyoma cell properties in human uterine smooth muscle cells.
Journal: F&S science
Published: December 07, 2021
A Revised Stem Cell Theory for the Pathogenesis of Endometriosis.
Journal: Journal of personalized medicine
Published: November 28, 2021
Limited Impact of Murine Placental MDR1 on Fetal Exposure of Certain Drugs Explained by Bypass Transfer Between Adjacent Syncytiotrophoblast Layers.
Journal: Pharmaceutical research
Published: November 06, 2021
Two ovarian candidate enhancers, identified by time series enhancer RNA analyses, harbor rare genetic variations identified in ovarian insufficiency.
Journal: Human molecular genetics
Published: October 14, 2021
Sorafenib targets and inhibits the oncogenic properties of endometrial cancer stem cells via the RAF/ERK pathway.
Journal: Stem cell research & therapy
Published: June 29, 2021
Last Updated: 09/26/2026